4620-47-7

Basic information

• Product Name: 3-(Benzoyloxy)-2,4-pentanedione
• Synonyms: 3-(Benzoyloxy)-2,4-pentanedione;2,4-dioxopentan-3-yl benzoate
• CAS NO: 4620-47-7
• Molecular Formula: C₁₂H₁₂O₄
• Molecular Weight: 220.2213
• Mol File: 4620-47-7.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 373.4°Cat760mmHg
• Flash Point: 167°C
• Appearance: /
• Density: 1.171g/cm³
• Vapor Pressure: 9.02E-06mmHg at 25°C
• Refractive Index: 1.513
• CAS DataBase Reference: 3-(Benzoyloxy)-2,4-pentanedione(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Benzoyloxy)-2,4-pentanedione(4620-47-7)
• EPA Substance Registry System: 3-(Benzoyloxy)-2,4-pentanedione(4620-47-7)

Safety Data

• Hazardous Substances Data: 4620-47-7(Hazardous Substances Data)

Usage

General Description

3-(Benzoyloxy)-2,4-pentanedione, also known as benzoylacetone, is a chemical compound with the molecular formula C13H12O3. It is a yellow crystalline powder with a molecular weight of 216.23 g/mol. 3-(Benzoyloxy)-2,4-pentanedione is commonly used as a building block in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and fragrances. It is also used as a starting material for the preparation of chelating ligands and metal complexes. Additionally, 3-(Benzoyloxy)-2,4-pentanedione is known for its potential antiviral and antibacterial properties, making it a promising candidate for the development of new therapeutic agents. However, its specific biological activities and mechanisms of action are still the subject of ongoing research.

InChI:InChI=1/C12H12O4/c1-8(13)11(9(2)14)16-12(15)10-6-4-3-5-7-10/h3-7,11H,1-2H3

Upstream product

• 123-54-6 acetylacetone 
• 29397-21-5 Diacetyldiazomethan 
• 65-85-0 benzoic acid 
• 108-88-3 toluene 
• 1694-29-7 3-chloropentane-2,4-dione 
• 532-32-1 sodium benzoate 
• 94-36-0 dibenzoyl peroxide 

Relevant articles and documents

MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF

Disclosed herein are compounds, compositions, and methods for modulating the monocarboxylic acid transporter 4 (MCT4) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by

THERAPEUTIC COMPOUNDS

The present disclosure relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of diseases mediated by aberrant cell signalling, such as inflammatory disorders, cancer and neoplastic disease.

METHOD FOR PRODUCING ALPHA-ACYLOXYCARBONYL COMPOUND AND NOVEL ALPHA-ACYLOXYCARBONYL COMPOUND

A method for producing an α-acyloxycarbonyl compound of the present invention includes performing an intermolecular reaction between a carboxylic acid and a carbonyl compound selected from the group consisting of ketones, aldehydes, and esters, which have